This page features ACC's full coverage of the latest science from Transcatheter Cardiovascular Therapeutics (TCT) 2026, taking place Oct. 31 to Nov. 3, 2026 in San Diego, CA.

A new 2026 ACC Expert Consensus Decision Pathway focuses on “Optimizing Blood Pressure Care in Patients With Resistant Hypertension” and addresses implementation gaps not covered in the 2025 ...

The size of a person’s midsection is a better indicator of cardiovascular disease risk when compared to their body mass index (BMI) alone, according to a study published in JACC, the flagship journal ...

Even with robust evidence demonstrating their efficacy and safety, direct oral anticoagulants (DOACs) continue to be underused and, at times, inappropriately dosed, particularly in patients at ...

The new 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the "interrelated ...

People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events a year later compared with those who did not get the vaccine, according to a study being ...

The new ACC/AHA Guideline for the Evaluation and Management of Acute Pulmonary Embolism (PE) in Adults is a de novo document offering comprehensive, evidence‑based recommendations for the evaluation, ...

In an effort to clearly understand the state of cardiovascular health in the U.S., the inaugural JACC Cardiovascular Statistics 2026 report offers a comprehensive picture of the major cardiovascular ...

Tirzepatide was noninferior to dulaglutide among patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD), with respect to the primary composite outcome of cardiovascular ...

Compared with placebo, PCSK9 inhibition with evolocumab reduced the risk of first cardiovascular events among patients with atherosclerosis or diabetes and without a previous myocardial infarction or ...

Cardiovascular diseases (CVD) remain the leading cause of disease burden , causing one in three deaths worldwide as a result of population growth, population aging and exposure to a broad range of ...

The American College of Cardiology (ACC) has issued guidance to help clinicians and patients use health data collected while wearing Apple Watch to effectively track and manage cardiovascular health. ...